Document is current
Any future updates will be listed below
-
Authors
Song, Ge
He, Wan-ting
Callaghan, Sean
Anzanello, Fabio
Huang, Deli https://orcid.org/0000-0002-6989-639X
Ricketts, James https://orcid.org/0000-0002-9057-5937
Torres, Jonathan L. https://orcid.org/0000-0003-0137-8497
Beutler, Nathan https://orcid.org/0000-0003-3240-9524
Peng, Linghang
Vargas, Sirena
Cassell, Jon
Parren, Mara
Yang, Linlin
Ignacio, Caroline
Smith, Davey M.
Voss, James E. https://orcid.org/0000-0002-4777-1596
Nemazee, David https://orcid.org/0000-0002-4769-6311
Ward, Andrew B. https://orcid.org/0000-0001-7153-3769
Rogers, Thomas
Burton, Dennis R. https://orcid.org/0000-0001-6711-9864
Andrabi, Raiees https://orcid.org/0000-0001-8837-7520
- License Information
-
More Information
Article History
Received: 18 September 2020
Accepted: 8 April 2021
First Online: 19 May 2021
Competing interests
: R.A., G.S., W.H., T.F.R., and D.R.B. are listed as inventors on pending patent applications describing the SARS-CoV-2 and HCoV-HKU1 S cross-reactive antibodies. D.R.B. is a consultant for IAVI. All other authors have no competing interests to declare.
